ALA 3.45% 14.0¢ arovella therapeutics limited

Nice little write up in the AFR today. Only a small section as...

  1. 260 Posts.
    lightbulb Created with Sketch. 30
    Nice little write up in the AFR today. Only a small section as part of a larger piece but hopefully get some exposure

    Arovella Therapeutics: if this succeeds, it’s “probably the cheapest biotech stock in the world right now”, says portfolio manager Andrew Chapman of Merchant Funds Management. The Merchant Opportunities Fund – focused on medicine and biotechnology – has generated compound returns of 16.65 per cent per year for 10 years, compared to the S&P/ASX Small Ordinaries Index at 2.94 per cent per year to June 30, 2023.“[The therapy] is close to being fully developed,” says Chapman. “It’s trying to develop a cell that will go into your body and kill cancers. I really think this technology has the ability and potential to revolutionise the way we treat complex cancers.” Arovella shares fetched 18¢ on February 12, on a market value around $167 million.

    Best-biotech-stocks-find-the-next-Pro-Medicus.pdf



    Last edited by Kelvin8r: edited to fix copy & paste errors 13/02/24
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
-0.005(3.45%)
Mkt cap ! $147.0M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $95.42K 662.9K

Buyers (Bids)

No. Vol. Price($)
6 168013 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 1440985 13
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.